Endocrine regulation of gonadotropin glycosylation

Archives of Medical Research

Volumn 32, Issue 6, 2001, Pages 520-532

  Ulloa Aguirre, Alfredo ^a   Maldonado, Angélica ^a   Damián Matsumura, Pablo ^a,b   Timossi, Carlos ^a  

^a INSTITUTO MEXICANO DEL SEGURO SOCIAL   (Mexico)

^b DEPARTAMENTO DE QUÍMICA   (Mexico)

Author keywords

Anterior pituitary; Carbohydrates; Glycosylation; Gonadotropins

Indexed keywords

CHORIONIC GONADOTROPIN; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; OLIGOSACCHARIDE; THYROTROPIN;

ADENOHYPOPHYSIS; ALPHA CHAIN; BETA CHAIN; GLYCOSYLATION; HORMONAL REGULATION; HORMONE ACTION; HORMONE STRUCTURE; HUMAN; HYPOPHYSIS GONAD SYSTEM; METABOLIC CLEARANCE RATE; NONHUMAN; REPRODUCTION; REVIEW; SIALYLATION; SIGNAL TRANSDUCTION; SULFATION;

AMINO ACID MOTIFS; ANDROGENS; ANIMALS; CARBOHYDRATE SEQUENCE; CASTRATION; CHORIONIC GONADOTROPIN; ENDOCRINE SYSTEM DISEASES; ENDOPLASMIC RETICULUM, ROUGH; ESTROGENS; FEMALE; FOLLICLE STIMULATING HORMONE; GLYCOSYLATION; GONADAL STEROID HORMONES; GONADOTROPIN-RELEASING HORMONE; GONADOTROPINS, PITUITARY; HUMANS; HYPOTHALAMO-HYPOPHYSEAL SYSTEM; LUTEINIZING HORMONE; MALE; MAMMALS; METABOLIC CLEARANCE RATE; MOLECULAR SEQUENCE DATA; N-ACETYLNEURAMINIC ACID; OLIGOSACCHARIDES; PITUITARY GLAND, ANTERIOR; PLACENTA; PREGNANCY; PROTEIN FOLDING; PROTEIN PROCESSING, POST-TRANSLATIONAL; RATS; STRUCTURE-ACTIVITY RELATIONSHIP; THYROTROPIN; THYROTROPIN-RELEASING HORMONE;

EID: 0035668922     PISSN: 01884409     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0188-4409(01)00319-8     Document Type: Review

References (123)

1. Immunocytochemical evidence that luteinizing hormone (LH) and follicle-stimulating hormone (FSH) are present in the same cell type in the rhesus monkey pituitary gland
2. Glycoprotein hormones: Structure and function
3. Immunohistochemical localization of a human chorionic gonadotropin-like substance in the human pituitary gland
4. Isolation and characterization of human pituitary chorionic gonadotropin
5. Human chorionic gonadotropin production by the pituitary gland in a premenopausal woman
6. Gonadotropins. Chemistry and biosynthesis
7. Structural features of mammalian gonadotropins
8. Molecular biology of the pituitary gonadotropins
9. A single gonadotropin alpha-subunit gene in normal tissue and tumor-derived cell lines
10. Alpha subunit of rat pituitary glycoprotein hormones. Primary structure of the precursor determined from the nucleotide sequence of cloned cDNAs
11. Structure, expression, and evolution of the genes for the human glycoprotein hormones
12. Organization and nucleotide sequence of the mouse alpha-subunit gene of the pituitary glycoprotein hormones
13. Regulation of pituitary gonadotrophin gene expression
14. The gonadotropin genes: Evolution of distinct mechanisms for hormonal control
15. Biologically active hormones prepared by recombination of the alpha chain of human chorionic gonadotropin and the hormone-specific chain of bovine thyrotropin or of bovine luteinizing hormone
16. Pituitary glycoprotein hormone oligosaccharides: Structure, synthesis and function of the asparagine-linked oligosaccharides on lutropin, follitropin and thyrotropin
17. The role of the aspargine-linked oligosaccharides of the α subunit in the secretion and assembly of human chorionic gonadotropin
18. Site-specific mutagenesis defines the intracellular role of the aspargine-linked oligosaccharides of chorionic gonadotropin β subunit
19. Mutagenesis and gene transfer define site-specific roles of the gonadotropin oligosaccharides
20. The carboxyl-terminal region is a determinant for the intracellular behavior of the chorionic gonadotropin β subunit: Effects on the processing of the Asn-linked oligosaccharides
21. Role of glycosylation in function of follicle-stimulating hormone
22. Intracellular functions of N-linked glycans
23. A pituitary N-acetylgalactosamine transferase that specifically recognizes glycoprotein hormones
24. Recognition by the glycoprotein hormone-specific N-acetylgalactosaminetransferase is independent of hormone native conformation
25. Molecular basis of recognition by the glycoprotein hormone-specific N-acetylgalactosamine-transferase
26. The molecular and cell biology of glycosyltransferases
27. Oestrogens regulate pituitary α2, 3-sialyltransferase messenger ribonucleic acid levels in the female rat
28. Estrogen modulates expression of the glycosyltransferases that synthesize sulfated oligosaccharides on lutropin
29. Some qualitative differences of hCG in serum from early and late pregnancies and trophoblastic disease
30. Median charge and charge heterogeneity of human pituitary FSH, LH and TSH. II. Relationship to sex and age
31. Structural and functional characterisation of hFSH and hLH isoforms
32. Reactivity of different LH and FSH standards and preparations in the World Health Organization matched reagents for enzyme-linked immunoassays of gonadotrophins
33. Biological characterization of the naturally occurring analogues of intrapituitary human follicle-stimulating hormone
34. Follicle-stimulating isoforms: Characterization and physiological relevance
35. Modulation of serum follicle-stimulating hormone bioactivity and isoforms distribution by estrogenic steroids in normal women and in gonadal dysgenesis
36. Follicle-stimulating hormones in anterior pituitary glands from children and adults differ in relation to sex and age
37. More basic forms of both human follicle-stimulating hormone and luteinizing hormone in serum at midcycle compared with the follicular or luteal phase
38. Dynamics of basal and gonadotropin-releasing hormone-releasable serum follicle-stimulating hormone charge isoform distribution throughout the human menstrual cycle
39. Glycoform composition of serum gonadotrophins through the normal menstrual cycle and in the post-menopausal state
40. Structure-function relationship of follicle-stimulating hormone and its receptor
41. Localization of antisera to LHβ and FSHβ in the rat pituitary gland
42. Gonadotropin alpha subunit. Differential processing of free and combined forms in human trophoblast and transfected mouse cells
43. Site-specific processing of the N-linked oligosaccharides of the human chorionic gonadotropin α subunit
44. A role for glycosylation of the α subunit in transduction of biological signal in glycoprotein hormones
45. Role of carbohydrates in glycoprotein hormone signal transduction
46. The sialylated oligosaccharides of recombinant bovine lutropin modulate hormone bioactivity
47. The role of sialic acid in determining the survival of glycoprotein hormones in the circulation
48. More in-vitro bioactive, shorter-lived human chorionic gonadotrophin charge isoforms increase at the end of the first and during the third trimesters of gestation
49. 4-4GalNAc beta 1, 4GlcNAc beta 1, 2Man alpha that mediates rapid clearance of lutropin
50. 4-4-GalNAcβ1, 4GlcNAcβ1, 2Manα-specific receptor from rat liver
51. Biochemical and functional aspects of gonadotrophin-releasing hormone and gonadotrophins
52. Altered biologic and immunologic activities of progressively desialylated human urinary FSH
53. In vitro and in vivo bioactivity of recombinant human follicle-stimulating hormone and partially deglycosylated variants secreted by transfected eukaryotic cell lines
54. Both of the β-subunit carbohydrate residues of follicle-stimulating hormone determine the metabolic clearance rate and in vivo potency
55. Site specificity of the chorionic gonadotropin N-linked oligosaccharides in signal transduction
56. Receptor binding and signal transduction are dissociable functions requiring different sites on follicle-stimulating hormone
57. Specific roles for the asparagine-linked carbohydrate residues of recombinant human follicle stimulating hormone in receptor binding and signal transduction
58. Site-directed mutagenesis defines the individual roles of the glycosylation sites on follicle-stimulating hormone
59. Discrepancies between radioimmunoassays and bioassays for rat FSH: Evidence that androgen treatment and withdrawal can alter bioassay-immunoassay ratios
60. FSH pleomorphism in the rat - Regulation by gonadal steroids
61. The effects of ovariectomy, estrogen replacement and neuraminidase treatment on the properties of the adenohypophyseal glycoprotein hormones of the rhesus monkey
62. Qualitative changes in the pituitary gonadotropins of the male Rhesus monkey following castration
63. Gonadal function and the biological and physicochemical properties of follicle-stimulating hormone
64. Biosynthesis and secretion of follicle-stimulating hormone
65. Immunological and biological potencies of the different molecular species of gonadotrophins
66. Changes in the isoforms of luteinizing hormone and follicle-stimulating hormone during puberty in normal children
67. Circulating bioactive follicle-stimulating hormone and less acidic follicle-stimulating hormone isoforms increase during experimental induction of puberty in the female lamb
68. Male and female forms of human follicle-stimulating hormone in serum
69. Les facteurs intrinsèques et extrinsèques qui influencent la stimulation des gonados et la réceptivité des tissus génitaux méminins. Formes circulantes des gonadotrophines et leur variabilité. Les gonadotrophines ches l'homme
70. Disappearance of endogenous luteinizing hormone is prolonged in postmenopausal women
71. 17β-oestradiol counteracts the formation of the more acidic isoforms of follicle-stimulating hormone and luteinizing hormone after menopause
72. Preponderance of basic isoforms of serum luteinizing hormone (LH) is associated with the high bio/immuno ratio of LH in healthy women and in women with polycystic ovarian disease
73. A preponderance of basic luteinizing hormone (LH) isoforms accompanies inappropriate hypersecretion of both basal and pulsatile LH in adolescents with polycystic ovarian syndrome
74. A preponderance of circulating basic isoforms is associated with decreased plasma half-life and biological to immunological ratio of gonadotropin-releasing hormone-releasable luteinizing hormone in obese men
75. Low serum testosterone and sex hormone binding globulin in massively obese men
76. Depressed plasma testosterone and fractional binding of testosterone in obese males
77. Attenuated luteinizing hormone (LH) pulse amplitude but normal LH pulse frequency, and its relation to plasma androgens in hypogonadism of obese men
78. 17-beta-estradiol potentiates luteinizing hormone glycosylation and release induced by veratridine, diacylglycerol, and phospholipase C in rat anterior pituitary cells
79. Estrogen regulation of α2, 3-sialyltransferase mRNA expression in gonadotropes: An in situ hybridization study
80. β-1, 4-galactosyltransferase and α-mannosidase-II messenger ribonucleic acid levels increase with different kinetics in thyrotrophs of hypothyroid mice
81. Sialyltransferase messenger ribonucleic acid increases in thyrotrophs of hypothyroid mice: An in situ hybridization study
82. Changes in the degree of sialylation of carbohydrate chains modify the biological properties of circulating thyrotropin isoforms in various physiological and pathological states
83. Modulation of human thyrotropin oligosaccharide structures-enhanced proportion of sialylated and terminally galactosylated serum thyrotropin isoforms in subclinical and overt hypothyroidism
84. Alterations in the sialylation and sulfation of secreted mouse thyrotropin in primary hypothyroidism
85. Changes in the sialylation and sulfation of secreted thyrotropin in congenital hypothyroidism
86. Influence of gonadectomy on isoelectrofocusing profiles of pituitary gonadotropins in rhesus monkeys
87. Immunological and biological activities of pituitary FSH isoforms in prepubertal male rats: Effect of antiandrogens
88. Modulation of serum and pituitary luteinizing hormone bioactivity by androgen in the rat
89. Ovine luteinizing hormone heterogeneity: Androgens increase the percentage of less basic isohormones
90. Changes in the qualitative and quantitative secretion of luteinizing hormone (LH) following orchidectomy in man
91. Less acidic forms of luteinizing hormone are associated with lower testosterone secretion in men on haemodialysis treatment
92. Specific regulatory actions of dihydrotestosterone and estradiol on the dynamics of FSH secretion and clearance in humans
93. FSH isoforms, radioimmunoassays, bioassays, and their significance
94. Molecular heterogeneity of serum follicle-stimulating hormone in hypogonadal patients before and during androgen replacement therapy and in normal men
95. Serum thyrotropin (TSH) heterogeneity in euthyroid subjects and patients with subclinical hypothyroidism: The core fucose content of TSH-releasing hormone-released TSH is altered, but not the net charge of TSH
96. Effect of TRH on TSH glycosylation and biological action
97. Pre-translational and post-translational regulation of TSH: Relationship to bioactivity
98. More basic isoforms of serum gonadotropins during gonadotropin-releasing hormone agonist therapy in pubertal children
99. Effects of gonadotropin-releasing hormone on bioactivity of follicle-stimulating hormone (FSH) and microstructure of FSH, luteinizing hormone and sex hormone-binding globulin in a testosterone-based contraceptive trial: Evaluation of responders and non-responders
100. Changes in the biological-to-immunological ratio of basal and gonadotrophin-releasing hormone-releasable follicle-stimulating hormone during the follicular, preovulatory and luteal phases of the human menstrual cycle
101. Metabolic interfaces between growth and reproduction. III. Central mechanisms controlling LH secretion in the nutritionally growth-limited female lamb
102. Pulsatile administration of gonadotropin-releasing hormone does not alter the follicle-stimulating hormone (FSH) isoform distribution pattern of pituitary or circulating FSH in nutritionally growth-restricted ovariectomized lambs
103. Effects of androgens on bioactivity and immunoactivity of pituitary FSH in GnRH antagonist-treated male rats
104. Direct pituitary effects of testosterone and luteinizing hormone-releasing hormone upon follicle-stimulating hormone: Analyisis by radioimmuno- and radioreceptor assay
105. Effects of synthetic GnRH on incorporation of radioactive glucosamine, and amino acids into LH and total protein by rat pituitaries in vitro
106. Biologically active luteinizing hormone is secreted in episodic pulsations that vary in relation to stage of the menstrual cycle
107. Preferential release of bioactive luteinizing hormone in response to endogenous and low dose exogenous gonadotropin-releasing hormone pulses in man
108. Endogenous opiates modulate the pulsatile secretion of biologically active luteinizing hormone in man
109. Biosynthesis of gonadotropins by rat pituitary cells in culture and in pituitary homogenates: Effects of gonadotropin releasing hormone
110. Modifications of luteinizing hormone biosynthesis by gonadotropin releasing hormone, cycloheximide and actinomycin D
111. Variants of human chorionic gonadotropin from pregnant women and tumor patients recognized by monoclonal antibodies
112. Carbohydrate and peptide structure of the α- and β-subunits of human chorionic gonadotropin from normal and aberrant pregnancy and choriocarcinoma
113. Early pregnancy human chorionic gonadotropin (hCG) isoforms measured by an immunometric assay for choriocarcinoma-like hCG
114. Amplitude regulation of episodic release, in vitro biological to immunological ratio, and median charge of human chorionic gonadotropin in pregnancy
115. A change in the isoforms of human chorionic gonadotrophin occurs around the 13th week of gestation
116. Glycosylation changes in human chorionic gonadotropin and free alpha subunit as gestation progress
117. Glycoprotein hormones: Glycobiology of gonadotrophins, thyrotrophin and free α subunit
118. Luteinizing hormone-releasing hormone binds to enriched human placental membranes and stimulates in vitro the synthesis of bioactive human chorionic gonadotropin
119. Inhibin and activin modulate the release of gonadotropin-releasing hormone, human chorionic gonadotropin, and progesterone from cultured placental cells
120. Trophoblast-derived interleukin-6 (IL-6) regulates human chorionic gonadotropin release through IL-6 receptor on human trophoblasts
121. Tumor necrosis factor-I inhibits human chorionic gonadotropin secretion
122. Effect of insulin on human chorionic gonadotrophin secretion by placental explants
123. Studies on the microheterogeneity of chorionic gonadotropin secreted by the human cytotrophoblast in culture